Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC.Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump on Friday to voluntarily sell their medications for less, as his administration pushes to link the nation's drug prices to cheaper ones abroad.That includes Merck, Bristol Myers Squibb, Amgen ...